EndoSonics improves catheter imaging

Article

EndoSonics has received FDA 510(k) clearance for a third-generation intravascular ultrasound catheter the company calls the “Avanar.” The Avanar has upgraded integrated circuit technology to improve image quality for arterial sizing and

EndoSonics has received FDA 510(k) clearance for a third-generation intravascular ultrasound catheter the company calls the “Avanar.” The Avanar has upgraded integrated circuit technology to improve image quality for arterial sizing and definitive morphologic assessment, according to the firm. The device is part of EndoSonics’ digital intravascular ultrasound product line.

The Avanar has a smaller profile to allow easier and more rapid access through stents; tight lesions; and small, tortuous arteries. Reinhard J. Warnking, CEO and president of EndoSonics, said 80% of his company’s revenue comes from sales of disposable products such as the Avanar. EndoSonics is a Rancho Cordova, CA-based developer, manufacturer, and marketer of intravascular ultrasound imaging products.

Recent Videos
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
Related Content
© 2025 MJH Life Sciences

All rights reserved.